<div class="embed-responsive embed-responsive-16by9"><iframe width="640" height="360" style="max-width: 100%;max-height: 100%; border:none;" src="https://oncologytube.com/videoEmbed/28716/keynote-001-in-nsclc-results?channelName=obr&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit=" frameborder="0" allowfullscreen="allowfullscreen" allow="autoplay" scrolling="no">iFrame is not supported!</iframe></div>

KEYNOTE-001 in NSCLC Results

Name: KEYNOTE-001 in NSCLC Results
Uploaded: 2019-07-01T08:46:22
Duration: 1 min 41 s
Description: Naiyer Rizvi, MD, Price Family Professor of Medicine and Director of Thoracic Oncology, Co-Director of Cancer Immunotherapy, Columbia Irving Medical Center explains the results from KEYNOTE-001 which evaluated pembrolizumab in advanced non-small cell lung cancer (NSCLC).

00:01:41

Don

3 years 160 Views

Share Add to Report 0 0

Embed (Iframe):

<div class="embed-responsive embed-responsive-16by9"><iframe width="640" height="360" style="max-width: 100%;max-height: 100%; border:none;" src="https://oncologytube.com/videoEmbed/28716/keynote-001-in-nsclc-results?channelName=obr&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit=" frameborder="0" allowfullscreen="allowfullscreen" allow="autoplay" scrolling="no">iFrame is not supported!</iframe></div>

Embed (Object):

<div class="embed-responsive embed-responsive-16by9"><object width="640" height="360"><param name="movie" value="https://oncologytube.com/videoEmbed/28716/keynote-001-in-nsclc-results?channelName=obr&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit="></param><param name="allowFullScreen" value="true"></param><param name="allowscriptaccess" value="always"></param><embed src="https://oncologytube.com/videoEmbed/28716/keynote-001-in-nsclc-results?channelName=obr&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit=" allowscriptaccess="always" allowfullscreen="true" width="640" height="360"></embed></object></div>

Link (HTML):

<a href="https://oncologytube.com/v/28716?channelName=obr"><img src="https://oncologytubecom.cdn.ypt.me/videos/video_190701204622_50e7/video_190701204622_50e7.jpg?cache=15669160911678829655">KEYNOTE-001 in NSCLC Results</a>

Link (BBCode):

[url=https://oncologytube.com/v/28716?channelName=obr][img]https://oncologytubecom.cdn.ypt.me/videos/video_190701204622_50e7/video_190701204622_50e7.jpg?cache=15669160911678829655[/img]KEYNOTE-001 in NSCLC Results[/url]

Sign in now!

Permanent Link

URL Friendly (SEO)

Current Time (SEO)

Category:

Non-Small Cell Lung Cancer

Description:

Naiyer Rizvi, MD, Price Family Professor of Medicine and Director of Thoracic Oncology, Co-Director of Cancer Immunotherapy, Columbia Irving Medical Center explains the results from KEYNOTE-001 which evaluated pembrolizumab in advanced non-small cell lung cancer (NSCLC).